Drug
TD 1211
TD 1211: highest development phase Phase 2, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| TD-1211 NCT01401985 | Phase 2 | Opioid Induced Constipation |
| TD-1211 NCT01568411 | Phase 1 | Healthy |
Latest
No recent events.
Follow TD 1211 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.